TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test March 28, 2014
TCL Archive Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds April 25, 2003
TCL Archive In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says November 27, 1981
